- Home
- BRN vs CARM Comparison
BRN vs CARM Comparison
Compare BRN & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- CARM
- Stock Information
- Founded
- BRN 1956
- CARM 2016
- Country
- BRN United States
- CARM United States
- Employees
- BRN N/A
- CARM N/A
- Industry
- BRN Oil & Gas Production
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- BRN Energy
- CARM Health Care
- Exchange
- BRN Nasdaq
- CARM Nasdaq
- Market Cap
- BRN 16.9M
- CARM 17.4M
- IPO Year
- BRN N/A
- CARM N/A
- Fundamental
- Price
- BRN $1.65
- CARM $0.44
- Analyst Decision
- BRN
- CARM Hold
- Analyst Count
- BRN 0
- CARM 5
- Target Price
- BRN N/A
- CARM $4.57
- AVG Volume (30 Days)
- BRN 45.3K
- CARM 277.1K
- Earning Date
- BRN 02-10-2025
- CARM 11-07-2024
- Dividend Yield
- BRN N/A
- CARM N/A
- EPS Growth
- BRN N/A
- CARM N/A
- EPS
- BRN N/A
- CARM N/A
- Revenue
- BRN $21,724,000.00
- CARM $20,268,000.00
- Revenue This Year
- BRN N/A
- CARM $46.34
- Revenue Next Year
- BRN N/A
- CARM N/A
- P/E Ratio
- BRN N/A
- CARM N/A
- Revenue Growth
- BRN N/A
- CARM 41.13
- 52 Week Low
- BRN $1.31
- CARM $0.38
- 52 Week High
- BRN $3.20
- CARM $2.77
- Technical
- Relative Strength Index (RSI)
- BRN 53.09
- CARM 37.99
- Support Level
- BRN $1.53
- CARM $0.42
- Resistance Level
- BRN $1.69
- CARM $0.48
- Average True Range (ATR)
- BRN 0.12
- CARM 0.06
- MACD
- BRN 0.02
- CARM 0.01
- Stochastic Oscillator
- BRN 79.07
- CARM 18.67
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.